Contrarian Corpus
short seller full deck initial thesis
2019-01-23 · 128 pages

Amdocs Limited DOX

Spruce Point sees 25-50% downside in Amdocs (DOX): a Guernsey-domiciled telecom-IT vendor whose steady margins, opaque insider selling via Pines Quest, and dot-com-era accounting tricks signal $30-$45 per share.

N 4 Narrative
V 3 Visual
C 3 Craft
Unlock to download PDF Spruce Point research ↗

Thesis

Amdocs (NASDAQ: DOX), a Guernsey-domiciled provider of revenue management, BPO and IT services to telcos like AT&T, presents itself as a steady 6% Non-GAAP EPS grower — but Spruce Point argues the growth is manufactured. Despite spending $1.6bn on M&A since FY09, operating cash flow has compounded under 1%, GAAP EPS has actually contracted, and EBITDA margins are 5x less variable than peers — hallmarks of aggressive percentage-of-completion accounting and software-cost capitalization, including a $350M Israeli campus that obscures capex. Insiders own only 1.5% and have sold heavily through Pines Quest, an opaque BVI/Guernsey entity tied to the Panama Papers, while a director was previously named in Mercury Interactive's options-backdating case. With the same executives now repeating the 1999-2002 playbook that ended in a securities-fraud lawsuit, Spruce Point sees 25-50% downside to $30-$45 per share.

SCQA

Situation

Amdocs is a Guernsey-domiciled revenue management, BPO and IT services vendor serving major telcos like AT&T, marketed to investors as a steady-margin, M&A-fueled compounder generating ~6% Non-GAAP EPS growth and consistent buybacks.

Complication

Organic revenue is flat-to-declining, GAAP EPS has contracted, OCF has barely grown despite $1.6bn of acquisitions, and management is repeating the same accounting, opacity and insider-selling patterns that triggered a 2002 securities-fraud class action.

Resolution

Reset estimates to back out percentage-of-completion, software-cost capitalization and one-off tax benefits; reprice DOX as a no-growth BPO peer; and scrutinize the Pines Quest insider-selling vehicle, audit-committee history and option-grant practices.

Reward

Applying a peer-aligned 1.0-1.5x EV/Sales or 11-15x P/E on Spruce Point's adjusted ~$2.50 EPS yields a $30-$45 fair value — 25-50% downside, with potential for further declines as M&A and tax cushions exhaust.

The three reasons

  1. 1

    Suspiciously steady EBITDA margins (5x less variable than peers) signal aggressive percentage-of-completion accounting

  2. 2

    $1.6B of M&A since FY09 has produced <1% operating cash flow CAGR while GAAP EPS contracts

  3. 3

    Same executives repeating 1999-2002 playbook that triggered a securities-fraud lawsuit — 25-50% downside to $30-$45

Primary demands

  • Strong Sell recommendation on DOX shares
  • Investors and analysts should reset estimates to back out percentage-of-completion benefits, software-cost capitalization, and one-off tax items
  • Shareholders should scrutinize executive compensation, opaque Pines Quest insider selling, and audit-committee ties to prior accounting scandals
  • Treat DOX as a no-growth BPO/midcap-tech peer rather than a premium tech compounder

KPIs cited

EBITDA margin standard deviation (2013-2018)
Amdocs 0.0042 vs CSG 0.0193 vs AT&T 0.0272 — over 5x less variable than peers despite 7 acquisitions
Non-GAAP vs GAAP EPS CAGR since FY2015
Non-GAAP EPS +6.1% CAGR vs GAAP EPS -4.7% CAGR; non-GAAP adjustments grew from ~15% (FY13) to ~40% (FY18) of non-GAAP earnings
Operating cash flow growth
$1.6B spent on M&A since FY09 produced OCF growth from $519M to $557M — <1% CAGR over a decade
Insider ownership
Down from 80%+ post-IPO to ~1.5% today
Pines Quest insider selling
Sold ~$35M of stock in CY2017, ~$33M in CY2016, with two-year hiatus aligning with Gelman CEO appointment Nov 2010
One-off net tax benefits
Up to $60M per year (claimed $28M tied to new Israeli campus in FY2018) — ~10% of FY18 EBT
Israeli campus capex
$350M FY18-21 spend for a no-growth company; Electra Group construction estimate only NIS 300m (~$90m)
Premium to BPO/midcap-tech peer average
+62.5% on 2019E P/E, +38.3% EV/EBITDA, +22.1% EV/Sales
Sell-side average price target
$73.40 (~22% upside) — Spruce Point estimates ~25% downside to consensus EPS

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns. Orange cells are present in this deck; neutral cells are not.

Precedents cited

  • Caesarstone (Spruce Point 2015 short — two CEOs and two CFOs subsequently resigned)
  • IDB / IRSA / Cresud (Spruce Point 2015 short — Argentine conglomerate VCO accounting)
  • Mercury Interactive options-backdating SEC complaint (2008) — Director Giora Yaron previously named
  • Amdocs 2002 securities-fraud class action (Kerry Chambers et al. v. Amdocs) — accounting and disclosure playbook
  • Toes Corporation (Jersey trust used by Amdocs employees in 1990s) as analogue to Pines Quest

Composition what's on the 128 slides

Visual + textual elements counted across every slide in this deck. Hover a box for what that element is; click to see every slide in the corpus that uses it.

Slide gallery ·

All 128
No slide inventory yet

Pass-2 extraction may still be in progress for this deck.

Notes

Striking editorial cover (page 1) staging a rat next to an antique phone in front of a fake AdminLTE 'Revenue and Financial Management Dashboard' — title 'Re-DOX of Dot.com Stock Collapse?' Strong narrative spine framing this as a re-run of the 1999-2002 Amdocs accounting playbook, with a recurring 'Have We Seen This Before? YES' comparison table (pages 8-9). Heavy forensic-accounting backbone with quarterly per-acquisition revenue triangulation appendix (pages 113-128). Body is dense table-heavy institutional design rather than custom data-viz; cover is the visually distinctive asset. No stake disclosed — short position rather than long activist. Author/founder Ben Axler is identifiable but the document itself is firm-branded, not signed; Axler attributed via firm bio (page 3).